Position in SUPN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,885,546
+$2,058,018 QoQ
Shares Held
229,939
+16.3% QoQ
Ownership
0.396%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $70,326,489 across 14 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
229,939 | $11,885,546 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
469,916 | $11,245,089 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
157,126 | $9,312,858 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
272,786 | $9,021,033 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
406,175 | $7,956,968 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
|
2,626,995 | $7,197,966 | |
| 7 | SIGA |
Siga Technologies Inc
|
667,646 | $3,571,906 | |
| 8 | TKNO |
Alpha Teknova, Inc.
|
1,069,162 | $3,089,878 |
All Filings in SUPN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,885,546 | 229,939 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,827,528 | 197,737 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,948,159 | 40,765 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,024,526 | 32,504 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $805,060 | 24,582 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $467,838 | 12,938 | Shares | Sole | 2025-02-10 | |
| 2023-09-30 | $516,937 | 18,750 | Shares | Sole | 2023-11-09 | |
| 2023-03-31 | $1,580,316 | 43,619 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $1,562,453 | 43,803 | Shares | Sole | 2023-05-23 | |
| 2022-09-30 | $1,514,279 | 44,735 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,298,247 | 44,891 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,739,139 | 53,810 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $7,526,895 | 258,124 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $9,903,237 | 371,325 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $11,296,697 | 366,895 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $9,854,125 | 376,399 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,742,731 | 387,231 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $6,214,029 | 298,178 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,866,938 | 247,029 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $4,191,705 | 233,002 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||